Reduced drug accumulation in a newly established human lung squamous-carcinoma cell line resistant to cis-diamminedichloroplatinum(II)
- 1 July 1992
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 44 (2) , 394-397
- https://doi.org/10.1016/0006-2952(92)90027-g
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Characteristics of five human tumor cell lines and sublines resistant to cis‐diamminedichloroplatinum(II)International Journal of Cancer, 1991
- Determinants of Drug Response in a Cisplatin‐resistant Human Lung Cancer Cell LineJapanese Journal of Cancer Research, 1990
- Tumor Resistance to Alkylating Agents Conferred by Mechanisms Operative Only in VivoScience, 1990
- Overexpression of Metallothionein Confers Resistance to Anticancer DrugsScience, 1988
- Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II)Biochemistry, 1988
- Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cellsCancer Chemotherapy and Pharmacology, 1987
- Factors influencing the sensitivity of two human bladder carcinoma cell lines to cis-diamminedichloro-platinum(II)Chemico-Biological Interactions, 1987
- CisplatinAnnals of Internal Medicine, 1984
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983